Chinmaya IAS Academy – Current Affairs Chinmaya IAS Academy – Current Affairs
Related Articles
Context: Department of Biotechnology supported GCLP Facility for Viral Immunogenicity Testing now open for operations.
Department of Biotechnology, Government of India has taken myriads of initiatives to increase investments in research and development (R&D) of affordable Biotech healthcare products.
Establishment of National Biopharma Mission is one such endeavour to identify the needs and gaps of Biotherapeutics, Vaccine and Devices Industry and address those capacity bottlenecks.
Vaccine development requires extensive evaluation in humans to establish safety, immunogenicity and clinical efficacy. Centralized Viral and Bacterial clinical Immunogenicity labs meeting the stringent GCLP standards were therefore identified as a critical need for the vaccine Industry.
National Immunogenicity & Biologics Evaluation Center (NIBEC) for assessing clinical Immunogenicity of viral vaccines is established jointly by Bharati Vidyapeeth University through its constituent unit Interactive Research School for Health Affairs (IRSHA) and BIRAC-DBT, Government of India through National Biopharma Mission.
About DBT
The Department of Biotechnology (DBT), under the Ministry of Science & Technology, promotes and accelerates the development of biotechnology in India, including growth and application of biotechnology in the areas of agriculture, healthcare, animal sciences, environment and industry.
About BIRAC:
Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs
About National Biopharma Mission:
The Industry-Academia Collaborative Mission of Department of Biotechnology (DBT), Govt of India for accelerating discovery research to early development for Biopharmaceuticals approved by the Cabinet for a total cost US$ 250 million and 50% co-funded by the World Bank is being implemented at Biotechnology Research Assistance Council (BIRAC).
This program is dedicated to deliver affordable products to the nation with an aim to improve the health standards of India’s population. Vaccines, medical devices and diagnostics and biotherapeutics are few of its most important domains, besides, strengthening the clinical trial capacity and building technology transfer capabilities in the country.
About IRSHA:
Interactive Research School for Health Affairs (IRSHA) is a unique constituent unit of Bharati Vidyapeeth (Deemed to be University), totally dedicated to research. The institute was established in 2001.
The institute is mandated to conduct research in priority areas of human health in co-ordination with other constituents of the university like Medical, Ayurveda, Homeopathy, Dental colleges, Rajiv Gandhi Institute of IT & BT, Environmental sciences etc.
The core area of research includes Mother and child health, Cancer, Diabetes, Obesity, Osteoarthritis & Herbal medicine.
